Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001068879 | SCV001234012 | uncertain significance | not provided | 2021-08-27 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine with proline at codon 47 of the HOGA1 protein (p.Thr47Pro). The threonine residue is moderately conserved and there is a small physicochemical difference between threonine and proline. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with HOGA1-related conditions. Advanced modeling of experimental studies (such as gene expression, population dynamics, functional pathways, and cell-cycle effects in cell culture) performed at Invitae indicates that this missense variant is expected to disrupt HOGA1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV001068879 | SCV003808748 | uncertain significance | not provided | 2023-05-17 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001827454 | SCV002094515 | uncertain significance | Primary hyperoxaluria type 3 | 2021-06-17 | no assertion criteria provided | clinical testing |